Tech Company M&A Transactions

BioCatalytics Acquisition

BioCatalytics, operating out of Pasadena, was acquired by Codexis. The parties did not disclose the acquisition terms for the deal.

Transaction Overview

Company Name
Acquired By
Announced On
7/20/2007
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms of the transaction were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
129 N. Hill Ave. 103
Pasadena, CA 91106
USA
Email Address
Overview
BioCatalytics offers one of the broadest ranges of enzymes in the world for carrying out a variety of chemical reactions. In addition, we provide the expertise to guide your synthesis from conception to scale up.
Profile
BioCatalytics LinkedIn Company Profile
Social Media
BioCatalytics Company Twitter Account
Company News
BioCatalytics News
Facebook
BioCatalytics on Facebook
YouTube
BioCatalytics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Rozzell
  David  Rozzell LinkedIn Profile  David  Rozzell Twitter Account  David  Rozzell News  David  Rozzell on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/20/2007: PerQuest venture capital transaction
Next: 7/20/2007: ConteXtream venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary